North America 3D Printing in Healthcare Market Report by Offering, Technology, Application, Country and Company Analysis, 2025-2033

North America 3D Printing in Healthcare Market Size and Forecast

North America 3D Printing in Healthcare Market will grow from US$ 1.34 Billion in 2025 to US$ 3.1 Billion in 2034, at a Compound Annual Growth Rate (CAGR) of 9.75% from 2026–2034. Market expansion will be supported by increasing adoption of patient-specific implants, customized prosthetics, surgical guides, anatomical models, and 3D-printed medical devices.

What is 3D Printing in Healthcare and Its Uses & Popularity in North America

3D printing in healthcare is an additive manufacturing technology that creates physical medical products layer by layer from digital designs, CAD files, or patient imaging data. In North America, it is increasingly used for patient-specific implants, surgical guides, anatomical models, dental restorations, prosthetics, orthotics, and medical instruments. The U.S. FDA states that 3D printing can produce devices matched to individual patient anatomy and complex internal structures, supporting personalized treatment. The technology is particularly valuable in orthopedics, dentistry, reconstructive surgery, and surgical planning. FDA research indicates that it has cleared more than 100 devices manufactured using additive manufacturing technologies, demonstrating increasing regulatory adoption. North America accounted for approximately 39% of global healthcare 3D printing revenue in 2025, according to industry estimates, making it the largest regional market. Strong healthcare infrastructure, advanced medical-device manufacturing, university research, and investment in personalized medicine continue to strengthen regional adoption.

3D Printing in Healthcare Launches by Top 10 Countries in 2025

1. United States – Ricoh 3D for Healthcare

• Launch/Development: Ricoh established Ricoh 3D for Healthcare in 2025.
• The initiative focuses on point-of-care production of patient-specific, 3D-printed medical devices for hospitals and healthcare systems.
• Applications include customized anatomical models, surgical planning, and patient-specific medical devices.

2. Germany – 3D-Printed Medical Applications

• Launch/Development: Germany continued expanding additive manufacturing applications across orthopedic implants, surgical planning, dental devices, and patient-specific components in 2025.
• German healthcare and engineering ecosystems support commercialization of customized medical products and advanced manufacturing technologies.
• Germany represented a significant share of global healthcare 3D-printing activity in 2025, supported by its strong medical-device and industrial manufacturing base.

3. Switzerland – Patient-Specific PEEK Facial Implant

• Launch: 3D Systems and University Hospital Basel produced a 3D-printed PEEK facial implant in March 2025.
• The implant was described as the world’s first MDR-compliant 3D-printed facial implant manufactured at the point of care.
• It was produced using the EXT 220 MED printer and VESTAKEEP i4 3DF PEEK material.

4. China – Magnesium-Containing Biodegradable Bone Repair Material

• Launch: Shenzhen Zhongke Jingcheng Medical Technology received NMPA approval in May 2025 for a magnesium-containing biodegradable polymer bone-repair material.
• The product uses ultra-low-temperature 3D-printing technology for bone-defect treatment.
• It was described as China’s first magnesium-containing artificial bone-repair product approved through the innovative medical-device special review pathway.

5. India – Hospital-Based 3D Printing and VR Technology

• Launch: Amandeep Ujala Hospitals in Amritsar launched hospital-based 3D printing and virtual-reality technology in December 2025.
• The facility supports patient-specific anatomical models, surgical guides, customized implants, and surgical planning.
• Applications include orthopedics, trauma, spine, maxillofacial, and reconstructive procedures.

6. Ireland – Biofuse 3D-Printed Orthopedic Implant Technology

• Launch: Croom Medical introduced Biofuse in September 2025.
• The technology uses laser-powder-bed-fusion 3D printing to create interconnected porous lattice structures directly within orthopedic implants.
• It enables control over pore size, porosity, and lattice gradients to support bone ingrowth applications.

7. United Kingdom – 3D-Printed Medical Device Development

• Launch/Development: UK healthcare and medical-device organizations continued expanding 3D printing for surgical guides, anatomical models, dental products, implants, and prosthetics during 2025.
• The UK is identified as an important European market because of its combination of NHS clinical applications, university research, dental demand, and medical-device manufacturing capabilities.

8. Japan – Personalized Medical 3D Printing

• Launch/Development: Japan continued expanding 3D printing applications in patient-specific implants, surgical planning, dentistry, and precision medical manufacturing during 2025.
• Japan accounted for approximately 26% of Asia-Pacific healthcare 3D-printing revenue in 2025, according to industry estimates.
• Its advanced manufacturing and digital-health capabilities support adoption of customized medical solutions.

9. South Korea – Advanced Medical 3D Printing Research

• Launch/Development: South Korea continued developing healthcare 3D-printing technologies for precision medicine, tissue engineering, implants, and digital healthcare applications in 2025.
• Research centers have increasingly focused on advanced bioprinting and vascularized tissue applications.
• The country’s precision-manufacturing and digital-health ecosystem supports development of sophisticated additive-manufacturing technologies.

10. Canada – Patient-Specific and Clinical 3D Printing

• Launch/Development: Canadian hospitals, universities, and medical-technology companies expanded applications of 3D printing for surgical planning, dental products, anatomical models, prosthetics, and customized implants in 2025.
• Canada has more than 1,500 medical-device companies, providing an established ecosystem for medical technology development and commercialization.
• Research collaboration remains an important pathway for translating 3D-printing innovations into clinical applications.

Growth Driver of the Market

Rising Demand for Patient-Specific Medical Devices

Growing demand for personalized healthcare is a major driver of 3D printing adoption across North America. Unlike conventional manufacturing, additive manufacturing can produce implants, prosthetics, surgical guides, and other devices according to a patient’s individual anatomy. The FDA specifically recognizes patient-matched and patient-specific devices as important applications of 3D printing. Orthopedic and cranial implants, external prostheses, dental restorations, and surgical instruments can be manufactured with highly customized geometries. Demand for customized implants and prosthetics is also supported by an aging population and the prevalence of chronic and orthopedic conditions. As hospitals and medical-device companies increasingly integrate medical imaging, digital modeling, and additive manufacturing, 3D printing enables more individualized treatment planning and device production. This combination of customization, digital workflow integration, and clinical applications is expected to support continued market expansion.

Advanced Healthcare Infrastructure and Medical Technology Adoption

North America’s sophisticated healthcare infrastructure provides a strong foundation for the adoption of 3D printing technologies. The region has extensive networks of hospitals, academic medical centers, dental laboratories, medical-device manufacturers, and research institutions capable of integrating digital manufacturing into clinical workflows. In the United States, the FDA has established dedicated research programs examining additive-manufacturing processes, materials, software workflows, and quality controls for medical devices.  Canada also provides a substantial medical-device ecosystem, with more than 1,500 medical-device companies operating across the country. Healthcare providers increasingly use 3D-printed anatomical models for preoperative planning, while dental and orthopedic manufacturers utilize additive manufacturing for customized products. Continued investment in robotics, digital imaging, artificial intelligence, and advanced materials is creating complementary technologies that can improve 3D-printing workflows. These capabilities encourage hospitals and manufacturers to move beyond prototyping toward clinical and commercial applications.

Expansion of Dental, Orthopedic, and Surgical Applications

The expansion of 3D printing across dental, orthopedic, prosthetic, and surgical applications is creating multiple revenue opportunities in North America. The FDA identifies orthopedic and cranial implants, surgical instruments, dental restorations, and external prosthetics among established applications of medical 3D printing. Dental applications include crowns, bridges, dentures, orthodontic retainers, night guards, and other patient-matched products. Orthopedics is another important area because additive manufacturing can produce complex structures and customized implants from materials such as titanium and polymers.  As clinical applications become more established, hospitals and laboratories can use 3D printing to reduce dependence on conventional tooling and support rapid production of customized devices. Expansion into additional surgical specialties, combined with advances in biomaterials and software, is therefore broadening the addressable market across North America.

Challenges of the Market

Regulatory and Process-Validation Complexity

Regulatory requirements and process validation remain significant challenges for healthcare 3D printing in North America. Although additive manufacturing provides flexibility, medical devices must demonstrate appropriate safety, quality, and effectiveness for their intended applications. The FDA states that 3D-printed medical devices are generally subject to the same regulatory requirements as traditionally manufactured medical devices. The agency has identified uncertainty surrounding testing and validation of additive-manufacturing processes as a key regulatory-science challenge. Rapid changes in hardware, software, and materials can also increase the complexity of validation and regulatory review. Manufacturers must control material specifications, printer parameters, software workflows, production conditions, and post-processing procedures to maintain consistent quality. Patient-matched devices can introduce additional considerations because designs may vary between patients. These requirements can increase development timelines, compliance costs, and technical expertise requirements. Smaller medical-device companies and healthcare facilities may face particular difficulties establishing validated production environments. Greater standardization, automated process monitoring, and clearer regulatory pathways could help reduce these barriers as the market matures.

High Equipment, Materials, and Implementation Costs

High implementation costs can limit the adoption of advanced 3D printing technologies among smaller hospitals, clinics, laboratories, and medical-device manufacturers. Healthcare 3D printing requires more than purchasing a printer; organizations may need specialized software, qualified personnel, medical-grade materials, post-processing equipment, quality-control systems, and dedicated production environments. The FDA notes that additive manufacturing requires controls over materials, software workflows, process parameters, and testing to produce consistent medical devices. Complex systems using metal powders, high-performance polymers, or other specialized materials can require significant capital investment and technical expertise. Training clinicians, engineers, technicians, and quality personnel also adds to implementation expenses. In addition, facilities producing patient-specific devices must integrate imaging data and digital design workflows with manufacturing systems, creating additional IT and operational requirements. Canada’s medical-device market illustrates the importance of investment, with the country’s healthcare system spending approximately CAD$9,054 per person in 2024 across public and private healthcare. While long-term efficiency and customization benefits can offset costs, initial investment remains an important adoption barrier.

3D Printing in Healthcare Launches Worldwide

• Myrava Patient-Specific 3D Printed Bolus – USA, 2026: Myrava received FDA 510(k) clearance in September 2026 for a patient-specific 3D-printed bolus designed for radiation therapy. The device is manufactured according to each patient’s anatomy and radiation treatment plan.
• 3D MAC Titanium Cranial Plate System – USA, 2026: 3D Systems announced that Walter Reed’s 3D Medical Applications Center received FDA clearance for its patient-specific titanium cranial plate system, described as the first FDA-cleared implant granted to a point-of-care institution.
• Vitacore FormFit Custom-Fit CPAP Mask – Canada, 2026: Vitacore launched FormFit following Health Canada Medical Device Licence approval. The mask uses a smartphone facial scan to generate a 3D facial model and manufacture a customized medical-grade silicone CPAP mask.
• Nivalon EvoFlex Patient-Specific Spinal Implant – USA, 2026: Nivalon Medical Technologies produced a fully patient-specific, metal-free spinal implant using AI-driven design and advanced ceramic 3D printing. The implant is digitally designed from patient CT data.
• 3D Systems EXT 220 MED Point-of-Care Facial Implant – Switzerland, 2025: 3D Systems and University Hospital Basel produced what they described as the world’s first MDR-compliant 3D-printed PEEK facial implant at the point of care, using the EXT 220 MED printer and VESTAKEEP i4 3DF PEEK material.
• Ricoh 3D for Healthcare – USA, 2025: Ricoh established Ricoh 3D for Healthcare to accelerate point-of-care production of FDA-cleared, patient-specific 3D-printed medical devices for hospitals and healthcare systems.
• Materialise Bioresorbable Tracheobronchial Splint – USA, 2025: Materialise and the University of Michigan entered an FDA pivotal clinical trial for a bioresorbable, 3D-printed tracheobronchial splint intended to support treatment of children with severe airway conditions.
• Stratasys RadioMatrix and Digital Anatomy Medical Imaging Phantoms – Global, 2025: Stratasys and Siemens Healthineers presented patient-specific 3D-printed imaging phantoms designed to replicate human anatomy for CT imaging research, AI algorithm development, surgical planning, and medical education.
• Ricoh 3D for Healthcare Innovation Studio – USA, 2024: Ricoh launched its point-of-care 3D medical-device manufacturing facility at Atrium Health Wake Forest Baptist in North Carolina, providing clinicians with on-site access to patient-specific 3D-printed anatomical models for surgical planning and patient education.
• 3D-Printed Patient-Specific Medical Devices Expansion – Worldwide: Healthcare 3D printing continues expanding from anatomical models and surgical guides into implants, prosthetics, and other patient-specific devices. The FDA identifies commercially available 3D-printed medical applications including surgical instrumentation, implants, and external prostheses.

United States Advanced Medical Infrastructure and Strong R&D Ecosystem

United States dominates North America’s 3D printing in healthcare landscape because of its advanced healthcare infrastructure, substantial medical research base, and strong medical-device industry. The U.S. FDA has established dedicated programs for evaluating additive manufacturing, covering materials, processes, software, and quality considerations for 3D-printed medical devices. The agency reports that more than 100 medical devices manufactured using additive manufacturing technologies have been cleared, demonstrating increasing regulatory experience with the technology.  3D printing is used across orthopedics, dentistry, reconstructive surgery, prosthetics, surgical planning, and anatomical modeling. Hospitals increasingly use patient imaging data to produce customized anatomical models and surgical guides, while manufacturers use additive manufacturing for patient-specific implants and complex geometries. The U.S. market also benefits from collaborations among universities, hospitals, technology companies, and medical-device manufacturers. Growing interest in personalized medicine, bioprinting research, advanced biomaterials, and digitally integrated healthcare is expanding applications. However, equipment investment, process validation, and regulatory compliance remain important considerations for broader adoption.

Canada Research Collaboration and Personalized Healthcare Applications

Canada’s 3D printing in healthcare market is developing through collaborations among hospitals, universities, research organizations, and medical-technology companies. The country has more than 1,500 medical-device companies, providing a broad ecosystem for medical technology development and commercialization.  3D printing applications include customized implants, surgical planning models, dental products, prosthetics, and anatomical models for medical education. Academic and healthcare institutions are particularly important because they provide expertise in biomedical engineering, digital imaging, materials science, and clinical research. Additive manufacturing can allow healthcare providers to convert CT and MRI data into patient-specific physical models, supporting preoperative planning and education. Canada’s healthcare expenditure reached approximately CAD$9,054 per person in 2024, reflecting the scale of the country’s healthcare system and its capacity for technology adoption.  However, high equipment and material costs can limit adoption by smaller facilities, while Canada’s geographic size can create accessibility challenges for rural and remote healthcare providers. Continued research funding, digital-health development, and partnerships with manufacturers can support wider clinical adoption.

Mexico Expanding Medical Technology Adoption and Dental Applications

Mexico represents an emerging market for healthcare 3D printing, with adoption increasingly concentrated in dentistry, orthopedics, prosthetics, surgical planning, and medical education. The country’s medical-device sector provides an important foundation for technology development, while proximity to the United States supports manufacturing relationships, technology transfer, and access to advanced medical technologies. Mexico’s medical-device industry is strongly integrated with North American supply chains, particularly through manufacturing clusters in regions such as Baja California, Chihuahua, and other industrial centers. 3D printing can support the production of customized dental components, anatomical models, surgical guides, and prosthetic devices while reducing the need for conventional tooling in certain applications. Universities and research institutions are also exploring additive manufacturing for biomedical engineering and clinical education. Nevertheless, adoption remains constrained by equipment and material costs, shortages of specialized technical expertise, and differences in healthcare-technology access between major cities and rural areas. As hospitals modernize and digital healthcare capabilities expand, increasing awareness of customized treatment and rapid manufacturing is expected to create additional opportunities for 3D printing across Mexico’s healthcare sector.

Market Segmentations

Offering

• System
• Materials
• Services

Technology

• Droplet Deposition
• Photopolymerization
• Laser Beam Melting
• Electronic Beam Melting
• Laminated Object Manufacturing
• Others

Application

• Dental
• Wearable Devices
• Prosthetics
• Medical Implants
• Tissue Engineering
• Others 

Country

• United States
• Canada

All the Key players have been covered

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis:

• 3D Systems Corporation
• Exone Company
• Formlabs Inc.
• General Electric
• Materialise NV
• Oxferd Performance Materials, Inc.
• Organovo Holdings, Inc.

Report Details: